Manifestations of gMG therefore commonly include muscle weakness, which patients often initially notice in their eye movements or jaw
We also recommend schedule and combination designs that maintain lesion pressure while protecting normal tissues
The rare adverse events seen with Retatrutide (pancreatitis, gallbladder issues, kidney problems) match what occurs with established GLP-1 medications, suggesting no unique long-term risks
In comparison, tirzepatide showed the following side effects in clinical trials: However, the overall treatment discontinuation rates in patients taking orforglipron were 21.9% (6 mg), 22.5% (12 mg), and 24.4% (36 mg) vs
Baum HB, Katznelson L, Sherman JC, Biller BM, Hayden DL, Schoenfeld DA, et al
Fresh & Subtle